These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives. Sakamoto J, Morita S, Kodera Y, Rahman M, Nakao A. Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S25-31. PubMed ID: 15309511 [Abstract] [Full Text] [Related]
3. Laparoscopic pelvic autonomic nerve-preserving surgery for patients with lower rectal cancer after chemoradiation therapy. Liang JT, Lai HS, Lee PH. Ann Surg Oncol; 2007 Apr; 14(4):1285-7. PubMed ID: 17235719 [Abstract] [Full Text] [Related]
4. Rectal cancer surgery and regional lymph nodes. Simunovic M, Smith AJ, Heald RJ. J Surg Oncol; 2009 Mar 15; 99(4):256-9. PubMed ID: 19101955 [Abstract] [Full Text] [Related]
5. Surgical quality assurance in rectal cancer treatment: the key to improved outcome. Peeters KC, van de Velde CJ. Eur J Surg Oncol; 2005 Aug 15; 31(6):630-5. PubMed ID: 15878260 [Abstract] [Full Text] [Related]
6. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial. Akasu T, Moriya Y, Ohashi Y, Yoshida S, Shirao K, Kodaira S, National Surgical Adjuvant Study of Colorectal Cancer. Jpn J Clin Oncol; 2006 Apr 15; 36(4):237-44. PubMed ID: 16675478 [Abstract] [Full Text] [Related]
7. European trials with total mesorectal excision. Kapiteijn E, van De Velde CJ. Semin Surg Oncol; 2000 Dec 15; 19(4):350-7. PubMed ID: 11241917 [Abstract] [Full Text] [Related]
8. The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language. Glynne-Jones R, Mawdsley S, Novell JR. Colorectal Dis; 2006 Nov 15; 8(9):800-7. PubMed ID: 17032329 [Abstract] [Full Text] [Related]
9. Optimal locoregional treatment in gastric cancer. Jansen EP, Boot H, Verheij M, van de Velde CJ. J Clin Oncol; 2005 Jul 10; 23(20):4509-17. PubMed ID: 16002841 [Abstract] [Full Text] [Related]
10. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM). Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206 [Abstract] [Full Text] [Related]
11. Resection for gastric cancer in the community. van de Velde CJ. Semin Oncol; 2005 Dec 15; 32(6 Suppl 9):S90-3. PubMed ID: 16399441 [Abstract] [Full Text] [Related]
12. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma. Leong CN, Chung HT, Lee KM, Shakespeare TP, Mukherjee RK, Wong LC, Lu JJ, Tey J, Lim R, So JB, Back MF. Cancer J; 2008 Dec 15; 14(4):269-75. PubMed ID: 18677137 [Abstract] [Full Text] [Related]
13. Is local excision and chemoradiation an acceptable alternative in the treatment of early rectal cancer? Spiliotis JD, Datsis AC. J BUON; 2007 Dec 15; 12(1):23-7. PubMed ID: 17436397 [Abstract] [Full Text] [Related]
14. Overview of adjuvant therapy for resected gastric cancer: differences in Japan and the United States. Ohtsu A, Sasako M. Semin Oncol; 2005 Dec 15; 32(6 Suppl 9):S101-4. PubMed ID: 16399444 [Abstract] [Full Text] [Related]
15. The influence on treatment outcome of structuring rectal cancer care. Påhlman L, Gunnarsson U, Karlbom U. Eur J Surg Oncol; 2005 Aug 15; 31(6):645-9. PubMed ID: 15893909 [Abstract] [Full Text] [Related]
17. Surgical treatment of pancreatic cancer: the role of adjuvant and multimodal therapies. Kleeff J, Michalski CW, Friess H, Büchler MW. Eur J Surg Oncol; 2007 Sep 15; 33(7):817-23. PubMed ID: 17331695 [Abstract] [Full Text] [Related]
18. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group. Van Cutsem E, Van de Velde C, Roth A, Lordick F, Köhne CH, Cascinu S, Aapro M, European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group. Eur J Cancer; 2008 Jan 15; 44(2):182-94. PubMed ID: 18093827 [Abstract] [Full Text] [Related]
19. Current surgical management of rectal cancer. Kusunoki M, Inoue Y. Dig Surg; 2007 Jan 15; 24(2):115-9. PubMed ID: 17446705 [Abstract] [Full Text] [Related]
20. Perspectives in the treatment of gastric cancer. Roukos DH, Kappas AM. Nat Clin Pract Oncol; 2005 Feb 15; 2(2):98-107. PubMed ID: 16264882 [Abstract] [Full Text] [Related] Page: [Next] [New Search]